| For: | Nattiv R, Wojcicki JM, Garnett EA, Gupta N, Heyman MB. High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice. World J Gastroenterol 2012; 18(11): 1229-1234 [PMID: 22468086 DOI: 10.3748/wjg.v18.i11.1229] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i11/1229.htm |
| Number | Citing Articles |
| 1 |
Shomron Ben-Horin, Yehuda Chowers. Tailoring anti-TNF therapy in IBD: drug levels and disease activity. Nature Reviews Gastroenterology & Hepatology 2014; 11(4) doi: 10.1038/nrgastro.2013.253
|
| 2 |
Kenneth Grant, Jenilee Pohle, Robert Tran, Roy Nattiv. Impact of biologic induction dose and concomitant drugs on anti‐drug antibody formation in a pediatric IBD cohort with high Hispanic representation. JPGN Reports 2025; 6(4) doi: 10.1002/jpr3.70036
|
| 3 |
N. S. Ding, A. Hart, P. De Cruz. Systematic review: predicting and optimising response to anti‐TNF therapy in Crohn's disease – algorithm for practical management. Alimentary Pharmacology & Therapeutics 2016; 43(1) doi: 10.1111/apt.13445
|
| 4 |
Jiri Bronsky, Lissy de Ridder, Frank M. Ruemmele, Anne Griffiths, Stephan Buderus, Ondrej Hradsky, Almuthe Christina Hauer. Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases. Journal of Pediatric Gastroenterology and Nutrition 2019; 68(5) doi: 10.1097/MPG.0000000000002233
|
| 5 |
Steffen Dan‐Nielsen, Vibeke Wewer, Anders Paerregaard, Lars F. Hansen, Rasmus G. Nielsen, Aksel Lange, Christian Jakobsen. Does Infliximab Prevent Colectomy in Acute and Chronic Active Ulcerative Colitis?. Journal of Pediatric Gastroenterology and Nutrition 2014; 58(6) doi: 10.1097/MPG.0000000000000340
|
| 6 |
Ruben J. Colman, Jasbir Dhaliwal, Michael J. Rosen. Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision Medicine. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.634739
|
| 7 |
H.-I. Huppertz, H.W. Lehmann. Evidenz der Therapie chronisch-entzündlicher Erkrankungen in Kindheit und Adoleszenz mit Biologika. Zeitschrift für Rheumatologie 2014; 73(10) doi: 10.1007/s00393-014-1398-8
|
| 8 |
Logan Jerger, Jeffrey S. Hyams. Special considerations for biologic medications in pediatric ulcerative colitis. Expert Opinion on Biological Therapy 2020; 20(4) doi: 10.1080/14712598.2020.1685492
|
| 9 |
Marina Aloi, Federica Nuti, Laura Stronati, Salvatore Cucchiara. Advances in the medical management of paediatric IBD. Nature Reviews Gastroenterology & Hepatology 2014; 11(2) doi: 10.1038/nrgastro.2013.158
|
| 10 |
Konstantinos Papamichael, Ann Gils, Paul Rutgeerts, Barrett G. Levesque, Séverine Vermeire, William J. Sandborn, Niels Vande Casteele. Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD. Inflammatory Bowel Diseases 2015; 21(1) doi: 10.1097/MIB.0000000000000202
|